肺癌顺铂耐药的分子机制研究新进展_West China Medical Journal

Authors：

唐梦琳 ¹ , 邓万明 ²

Corresponding author：

Keywords：

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 唐梦琳,邓万明. 肺癌顺铂耐药的分子机制研究新进展. West China Medical Journal, 2009, 24(1): 238-240. doi: Copy

1.	Liu LZ，Zhou XD，Qian G，et al.AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway[J].Cancer Res 2007，67（13）:6325-6332..
2.	Hovelmann S，Beckers TL，Schmidt M.Molecular alterations in apoptotic pathways after PKB/Aktmediated chemoresistance in NCI H460 cells[J].Br J Cancer，2004，90（12）:23702377..
3.	Chattopadhyay S，MachadoPinilla R，ManguanGarcía C，et al.MKP1/CL100 controls tumor growth and sensitivity to cisplatin in nonsmallcell lung cancer[J].Oncogene，2006，25（23）:3335-3345..
4.	Ikuta K，Takemura K，Kihara M，et al.Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatinresistant human nonsmall cell lung cancer cells[J].Oncol Rep，2005，13（2）:217-222..
5.	Ivashkiv LB.JakSTAT signaling pathways in cells of the immune system[J].Rev Immunogenet，2000，2（2）:220-230..
6.	Ning ZQ，Li J，McGuinness M，et al.STAT3 activation is required for Asp（816）mutant cKit induced tumorigenicity[J].Oncogene，2001，20（33）:4528-4536.
7.	Wu C，Wangpaichitr M，Feun L，et al.Overcoming cisplatin resistance by mTOR inhibitor in lung cancer[J].Mol Cancer，2005，4（1）:25..
8.	Ohashi R，Takahashi F，Cui R，et al.Interaction between CD44 and hyaluronate induces chemoresistance in nonsmall cell lung cancer cell[J].Cancer Lett，2007，252（2）:225234..
9.	Ueda K，Kawashima H，Ohtani S，et al.The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatininduced resistance in human nonsmallcell lung cancer cells[J].Cancer Res，2006，66（19）:9682-9690.
10.	张梅春，胡成平，陈琼.survivin反义寡核苷酸提高人肺腺癌A549耐药细胞系对顺铂敏感性的研究[J].中华肿瘤学杂志，2006，28（6）：408-412..
11.	Li J，Viallet J，Haura EB A small molecule panBcl2 family inhibitor，GX15070，induces apoptosis and enhances cisplatininduced apoptosis in nonsmall cell lung cancer cells[J].Cancer Chemother Pharmacol，2008，61（3）:525-534..
12.	Reed MF，Zagorski WA，Knudsen ES.RB activity alters checkpoint response and chemosensitivity in lung cancer lines[J].J Surg Res，2007，142（2）:364-372..
13.	Gan PP，Pasquier E，Kavallaris M.Class Ⅲ βtubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer[J].Cancer Res，2007，67（19）:9356-9363..
14.	Su C，Su B，Tang L，et al.Effects of collagen Ⅳ on cisplatininduced apoptosis of nonsmall cell lung cancer Cells[J].Cancer Invest，2007:1-8..
15.	Bai L，Zhu R，Chen Z，et al.Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells[J].Biochem Pharmacol，2006，71（8）:1265-1271..
16.	张梅春，胡成平，陈琼，等.Survivin反义寡核苷酸治疗耐顺铂人肺腺癌细胞裸鼠移植瘤的实验研究[J].中南大学学报（医学版）,2006，31（5）：717-722.

1. Liu LZ，Zhou XD，Qian G，et al.AKT1 amplification regulates cisplatin resistance in human lung cancer cells through the mammalian target of rapamycin/p70S6K1 pathway[J].Cancer Res 2007，67（13）:6325-6332..
2. Hovelmann S，Beckers TL，Schmidt M.Molecular alterations in apoptotic pathways after PKB/Aktmediated chemoresistance in NCI H460 cells[J].Br J Cancer，2004，90（12）:23702377..
3. Chattopadhyay S，MachadoPinilla R，ManguanGarcía C，et al.MKP1/CL100 controls tumor growth and sensitivity to cisplatin in nonsmallcell lung cancer[J].Oncogene，2006，25（23）:3335-3345..
4. Ikuta K，Takemura K，Kihara M，et al.Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatinresistant human nonsmall cell lung cancer cells[J].Oncol Rep，2005，13（2）:217-222..
5. Ivashkiv LB.JakSTAT signaling pathways in cells of the immune system[J].Rev Immunogenet，2000，2（2）:220-230..
6. Ning ZQ，Li J，McGuinness M，et al.STAT3 activation is required for Asp（816）mutant cKit induced tumorigenicity[J].Oncogene，2001，20（33）:4528-4536.
7. Wu C，Wangpaichitr M，Feun L，et al.Overcoming cisplatin resistance by mTOR inhibitor in lung cancer[J].Mol Cancer，2005，4（1）:25..
8. Ohashi R，Takahashi F，Cui R，et al.Interaction between CD44 and hyaluronate induces chemoresistance in nonsmall cell lung cancer cell[J].Cancer Lett，2007，252（2）:225234..
9. Ueda K，Kawashima H，Ohtani S，et al.The 3p21.3 tumor suppressor NPRL2 plays an important role in cisplatininduced resistance in human nonsmallcell lung cancer cells[J].Cancer Res，2006，66（19）:9682-9690.
10. 张梅春，胡成平，陈琼.survivin反义寡核苷酸提高人肺腺癌A549耐药细胞系对顺铂敏感性的研究[J].中华肿瘤学杂志，2006，28（6）：408-412..
11. Li J，Viallet J，Haura EB A small molecule panBcl2 family inhibitor，GX15070，induces apoptosis and enhances cisplatininduced apoptosis in nonsmall cell lung cancer cells[J].Cancer Chemother Pharmacol，2008，61（3）:525-534..
12. Reed MF，Zagorski WA，Knudsen ES.RB activity alters checkpoint response and chemosensitivity in lung cancer lines[J].J Surg Res，2007，142（2）:364-372..
13. Gan PP，Pasquier E，Kavallaris M.Class Ⅲ βtubulin mediates sensitivity to chemotherapeutic drugs in non small cell lung cancer[J].Cancer Res，2007，67（19）:9356-9363..
14. Su C，Su B，Tang L，et al.Effects of collagen Ⅳ on cisplatininduced apoptosis of nonsmall cell lung cancer Cells[J].Cancer Invest，2007:1-8..
15. Bai L，Zhu R，Chen Z，et al.Potential role of short hairpin RNA targeting epidermal growth factor receptor in growth and sensitivity to drugs of human lung adenocarcinoma cells[J].Biochem Pharmacol，2006，71（8）:1265-1271..
16. 张梅春，胡成平，陈琼，等.Survivin反义寡核苷酸治疗耐顺铂人肺腺癌细胞裸鼠移植瘤的实验研究[J].中南大学学报（医学版）,2006，31（5）：717-722.

West China Medical Journal

肺癌顺铂耐药的分子机制研究新进展

Abstract Full text Figures/Tables Video References Cited by

Format

Content